|
Dr. Christopher W. Kemp has over thirty years of experience in the development of cellular based processes. For the past fifteen years Dr. Kemp has served as President of Kemp Biotechnologies Inc. a private contract manufacturing organization servicing the pharmaceutical research market.
Dr. Kemp founded Kemp Biotechnologies Inc. in 1992 subsequently acquired in 2006 by Pelican Life Sciences a life sciences research company backed by $100 million in equity capital commitments. Kemp Biotechnologies specialized in the scale-up of cellular based expression systems using novel bioreactor technologies. Prior to 1992 Dr. Christopher W. Kemp developed serum-free animal cell culture media formulation for BioWhittaker Inc. for seven years and previously at the National Institutes of Health in Bethesda MD worked on process development applications for the production of human vaccines where he received four awards during his decade-long tenure.
Dr. Christopher W. Kemp earned his Bachelor of Science degree in Microbiology from University of Maryland and a Master of Science degree in Biomedical Science from Hood College MD. He completed his PhD in Microbiology at George Washington University Washington DC. | 